High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium

Journal of Clinical Microbiology
Helen LeavisMarc J M Bonten

Abstract

To substantiate a common genetic background of ciprofloxacin-resistant Enterococcus faecium, 32 ciprofloxacin-resistant (Cip(r)) and 31 ciprofloxacin-susceptible (Cip(s)) isolates from outbreaks, clinical infections, surveillances, and animals from 10 different countries were genotyped by multilocus sequence typing. Additionally, susceptibilities to ampicillin and vancomycin and the presence of esp were determined and the quinolone resistance-determining regions of parC, gyrA, parB, and gyrE were sequenced. High-level Cip(r) (MIC > or = 64 microg/ml) due to point mutations in the quinolone resistance-determining region was unique to a distinct hospital-adapted genetic complex in E. faecium, previously designated CC17. Low-level Cip(r) (MIC = 4 microg/ml) in non-CC17 strains is not attributable to point mutations in any subunit of the topoisomerase genes, and the mechanism of resistance remains unclear. Acquisition of mutations in parC and gyrA, leading to high-level Cip(r), is, in addition to ampicillin resistance and the presence of a putative pathogenicity island, another cumulative step in hospital adaptation of CC17.

References

Oct 1, 1994·The Journal of Antimicrobial Chemotherapy·J Z JordensD T Griffiths
Apr 1, 1993·Antimicrobial Agents and Chemotherapy·P HeisigH Falkenstein-Paul
Dec 1, 1995·Antimicrobial Agents and Chemotherapy·G W Kaatz, S M Seo
Mar 1, 1996·Antimicrobial Agents and Chemotherapy·Y KumagaiH Ikeda
Apr 1, 1997·Antimicrobial Agents and Chemotherapy·C LynchH Nikaido
Feb 18, 1998·The Journal of Infectious Diseases·M J BontenR A Weinstein
Mar 31, 1998·Lancet·L Martínez-MartínezG A Jacoby
Jan 30, 1999·Antimicrobial Agents and Chemotherapy·H Fukuda, K Hiramatsu
Feb 27, 1999·Antimicrobial Agents and Chemotherapy·R J WillemsJ D van Embden
Apr 2, 1999·Antimicrobial Agents and Chemotherapy·N A el AminB Wretlind
Mar 9, 2000·The New England Journal of Medicine·B E Murray
Jun 8, 2000·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·S C MohnN Langeland
Nov 16, 2001·Antimicrobial Agents and Chemotherapy·B M JonasG M Weinstock
Mar 2, 2002·The Lancet Infectious Diseases·M J BontenR A Weinstein
Mar 7, 2002·Microbes and Infection·Brett D Shepard, Michael S Gilmore
May 23, 2002·Antimicrobial Agents and Chemotherapy·Yoshikuni OnoderaKenichi Sato
May 31, 2002·Journal of Clinical Microbiology·Wieger L HomanRob J L Willems
Dec 4, 2002·The Journal of Antimicrobial Chemotherapy·Jesús FortúnSantiago Moreno
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·George M Bahr
Mar 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Keith P Klugman
Apr 12, 2003·Journal of Clinical Microbiology·Javier Sánchez-CéspedesJordi Vila
Jun 25, 2003·Antimicrobial Agents and Chemotherapy·Minggui WangDavid C Hooper
Oct 2, 2003·Emerging Infectious Diseases·Helen L LeavisMarc J M Bonten
Nov 18, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·E TorellL G Burman

❮ Previous
Next ❯

Citations

Apr 6, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E SadowyW Hryniewicz
Jun 29, 2010·Foodborne Pathogens and Disease·Anette M HammerumOle E Heuer
Jun 15, 2012·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·María LópezCarmen Torres
Sep 25, 2008·The Journal of Antimicrobial Chemotherapy·Marieke J A de RegtMarc J M Bonten
Nov 13, 2008·The Journal of Antimicrobial Chemotherapy·Sylvia ValdezateJuan A Saéz-Nieto
Oct 7, 2008·Applied and Environmental Microbiology·Esther HeikensRob J L Willems
Feb 24, 2009·Applied and Environmental Microbiology·Peter DamborgLuca Guardabassi
Sep 11, 2007·Journal of Bacteriology·Esther HeikensRob J L Willems
Nov 6, 2007·Journal of Clinical Microbiology·Janetta TopMarc Bonten
Nov 10, 2009·Future Microbiology·Rob Jl Willems, Willem van Schaik
Dec 17, 2015·The Journal of Infectious Diseases·Maria Camila MontealegreBarbara E Murray
Dec 17, 2009·International Journal of Antimicrobial Agents·Guido WernerWolfgang Witte
Sep 22, 2009·The Journal of Infection·Neil Woodford, David M Livermore
Mar 8, 2008·International Journal of Medical Microbiology : IJMM·Wolfgang WitteGuido Werner
Jan 6, 2009·Journal of Applied Microbiology·H BillströmB Lund
Aug 2, 2006·Current Opinion in Microbiology·Helen L LeavisRob J L Willems
Oct 4, 2008·Microbiology·Antoni P A HendrickxRob J L Willems
Mar 12, 2013·The Science of the Total Environment·Ana Rita VarelaCélia M Manaia
Feb 12, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J TopM K Hayden
Oct 19, 2010·International Journal of Medical Microbiology : IJMM·Jenny A Laverde GomezGuido Werner
May 16, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Noriko UrushibaraNobumichi Kobayashi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

International Journal of Antimicrobial Agents
Guido WernerWolfgang Witte
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
Ingo KlareWolfgang Witte
© 2021 Meta ULC. All rights reserved